Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA
Yahoo/GuruFocus
Fri, 01/20/17 - 09:45 am
Boehringer Ingelheim
Humira
biosimilars
FDA
EMA
BI 695501
AbbVie
How Johnson & Johnson Beat Every Other Big Pharma Stock in 2016
Motley Fool
Thu, 01/19/17 - 11:26 am
JNJ
pharma stocks
AbbVie
Merck
This Army Vet Is Fighting Hep C With Big Pharma’s Help
Bloomberg
Thu, 12/29/16 - 10:18 am
hepatitis C
AbbVie
Merck
Gilead Sciences
3 Biggest Risks for AbbVie in 2017
Motley Fool
Wed, 12/28/16 - 11:03 am
AbbVie
Humira
biosimilars
Imbruvica
Viekira Pak
Elagolix
risankizumab
Galapagos, AbbVie glimpse early progress in search of a cystic fibrosis triple to rival Vertex
Endpoints
Wed, 12/21/16 - 11:10 am
Galapagos
AbbVie
Vertex Pharmaceuticals
cystic fibrosis
GLPG1837
AbbVie Files for Approval of Hepatitis C Treatment in the US
Yahoo/GuruFocus
Tue, 12/20/16 - 12:20 pm
AbbVie
hepatitis C
glecaprevir/pibrentasvir
Gilead's HCV NDA Means Nothing
Seeking Alpha
Sun, 12/11/16 - 11:55 am
Gilead Sciences
hepatitis C
SOF/VEL/VOX
Epclusa
AbbVie
Standing Up To The Test Of Time: Two Cancer Drugs That Could Survive A Hobbled FDA
Forbes
Thu, 12/8/16 - 09:59 am
FDA
Seattle Genetics
Takeda
Adcetris
Hodgkin's lymphoma
AbbVie
JNJ
Ibruvica
mantle cell lymphoma
AbbVie breast cancer drug falls short in Phase 2
BioPharma Dive
Wed, 12/7/16 - 07:45 pm
AbbVie
breast cancer
veliparib
PARP inhibitors
BRCA-mutant breast cancer
AbbVie and Johns Hopkins to Collaborate on Cancer Research
Yahoo
Mon, 12/5/16 - 09:55 am
AbbVie
Johns Hopkins
cancer
R&D
As Humira readies for biosimilar rivals, AbbVie looks to ASH to build oncology momentum
Fierce Pharma
Sat, 12/3/16 - 09:21 am
Humira
AbbVie
biosimilars
ASH
Elagolix May Become a Leading Uterine Fibroids Drug
Market Realist
Tue, 11/29/16 - 05:35 pm
uterine fibroids
Elagolix
AbbVie
Neurocrine Biosciences
AbbVie’s Imbruvica Expected to Become a Leading Oncology Drug
Market Realist
Tue, 11/29/16 - 09:46 am
AbbVie
Imbruvica
oncology
CLL
Gilead Takes Lead on Crohn's over AbbVie
Investopedia
Mon, 11/28/16 - 11:33 pm
Gilead Sciences
AbbVie
Crohn's Disease
Galapagos
filgotinib
ABT-494
AbbVie Ends Halozyme Development Deal
Investopedia
Tue, 11/22/16 - 09:43 pm
AbbVie
Halozyme
tnf-alpha
drug development
drug delivery
Halozyme shares drop after AbbVie punts a failed program; Celgene buys another cancer drug
Endpoints
Mon, 11/21/16 - 11:27 am
Halozyme
AbbVie
Celgene
marizomib
What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J
Fierce Pharma
Thu, 11/17/16 - 10:01 am
Gilead Sciences
Biogen
JNJ
drug launches
AbbVie
Sovaldi
Imbruvica
Tecfidera
After The Deluge, Hep C Players Look For Opportunity
Seeking Alpha
Thu, 11/17/16 - 09:57 am
hepatitis C
Gilead Sciences
AbbVie
Epclusa
glecaprevir/pibrentasvir
sofosbuvir/velpatasvir
AbbVie's Humira a Step Closer to Approval in Europe
Yahoo/GuruFocus
Wed, 11/16/16 - 09:50 am
AbbVie
Humira
Europe
AbbVie's pan-genotypic hep C prospect shines in trials, putting the heat on rival Gilead
Fierce Pharma
Tue, 11/15/16 - 09:36 am
AbbVie
hepatitis C
Gilead Sciences
Epclusa
Pages
« first
‹ previous
…
43
44
45
46
47
48
49
50
51
…
next ›
last »